Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

KAP/WTP and HPV Prevalence Studies in Preparation for a Phase IV Trial of the Gardasil HPV Vaccine in a Developing World Setting (Bamako, Mali)

NCT01314404 is registered in ClinicalTrials.gov with Global Alliance to Immunize Against AIDS Vaccine Foundation as lead sponsor.

NCT NCT01314404
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01314404 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
KAP/WTP and HPV Prevalence Studies in Preparation for a Phase IV Trial of the Gardasil HPV Vaccine in a Developing World Setting (Bamako, Mali)
Lead sponsor
Global Alliance to Immunize Against AIDS Vaccine Foundation
Phase
Observational
Overall status
Unknown status
Start date
March 31, 2011
Completion date
September 30, 2012
Enrollment
460 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

human papillomavirus